resveratrol has been researched along with Chagas Cardiomyopathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garg, NJ; Koo, SJ; Liang, LY; Wan, X; Wen, JJ | 1 |
| Bozza, MT; Carneiro, VC; Feijó, DF; Giarola, NL; Lannes-Vieira, J; Mata-Santos, H; Medei, E; Meyer-Fernandes, JR; Paiva, CN; Paula-Neto, HA; Ramos, IP; Vicentino, AR; Vilar-Pereira, G | 1 |
2 other study(ies) available for resveratrol and Chagas Cardiomyopathy
| Article | Year |
|---|---|
SIRT1-PGC1α-NFκB Pathway of Oxidative and Inflammatory Stress during Trypanosoma cruzi Infection: Benefits of SIRT1-Targeted Therapy in Improving Heart Function in Chagas Disease.
Topics: Animals; Antioxidants; Blotting, Western; Chagas Cardiomyopathy; Disease Models, Animal; Heart; Heterocyclic Compounds, 4 or More Rings; Humans; Inflammation; Mice; Mice, Inbred C57BL; NF-kappa B; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes; Transcriptome; Trypanosoma cruzi | 2016 |
Resveratrol Reverses Functional Chagas Heart Disease in Mice.
Topics: Animals; Antioxidants; Chagas Cardiomyopathy; Cyclic N-Oxides; Disease Models, Animal; Female; Male; Metformin; Mice; Mice, Inbred BALB C; Oxidative Stress; Resveratrol; Spin Labels; Stilbenes | 2016 |